BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ingram JR, Collier F, Brown D, Burton T, Burton J, Chin MF, Desai N, Goodacre TEE, Piguet V, Pink AE, Exton LS, Mohd Mustapa MF. British Association of Dermatologists guidelines for the management of hidradenitis suppurativa (acne inversa) 2018. Br J Dermatol. 2018;. [PMID: 30552762 DOI: 10.1111/bjd.17537] [Cited by in Crossref: 41] [Cited by in F6Publishing: 24] [Article Influence: 20.5] [Reference Citation Analysis]
Number Citing Articles
1 Orenstein LAV, Nguyen TV, Damiani G, Sayed C, Jemec GBE, Hamzavi I. Medical and Surgical Management of Hidradenitis Suppurativa: A Review of International Treatment Guidelines and Implementation in General Dermatology Practice. Dermatology 2020;236:393-412. [PMID: 32408306 DOI: 10.1159/000507323] [Cited by in Crossref: 11] [Cited by in F6Publishing: 8] [Article Influence: 11.0] [Reference Citation Analysis]
2 Cramer P, Schneider-Burrus S, Kovács M, Scholl L, Podda M, Bechara FG. [Hidradenitis suppurativa /acne inversa-surgical options, reconstruction and combinations with drug therapies-an update]. Hautarzt 2021;72:692-9. [PMID: 34228137 DOI: 10.1007/s00105-021-04864-8] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Takahashi T, Yamasaki K, Terui H, Omori R, Tsuchiyama K, Fujimura T, Aiba S. Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors: A case report and review of published cases. J Dermatol 2019;46:802-7. [PMID: 31271451 DOI: 10.1111/1346-8138.14998] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
4 Li Y, Li T, Chen L, Zhang L. Patient satisfaction and quality of life after surgery combined with 5-aminolevulinic acid-based photodynamic therapy for hidradenitis suppurativa. J Am Acad Dermatol 2021:S0190-9622(21)00140-7. [PMID: 33440214 DOI: 10.1016/j.jaad.2020.09.098] [Reference Citation Analysis]
5 Frew JW. Therapeutic biomarkers in hidradenitis suppurativa: one step closer to the clinic. Br J Dermatol 2021. [PMID: 34131898 DOI: 10.1111/bjd.20513] [Reference Citation Analysis]
6 Jemec GBE. Evidence-based hidradenitis suppurativa guidelines - and now all together please. Br J Dermatol 2019;180:975. [PMID: 31025736 DOI: 10.1111/bjd.17734] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
7 Esme P, Akoglu G, Sari O, Caliskan E. Family physicians' awareness and general knowledge of hidradenitis suppurativa: A survey research. Int J Clin Pract 2021;75:e14186. [PMID: 33780110 DOI: 10.1111/ijcp.14186] [Reference Citation Analysis]
8 Molinelli E, Sapigni C, Campanati A, Brisigotti V, Offidani A. Metabolic, pharmacokinetic, and toxicological issues of biologic therapies currently used in the treatment of hidradenitis suppurativa. Expert Opin Drug Metab Toxicol 2020;16:1019-37. [PMID: 32896186 DOI: 10.1080/17425255.2020.1810233] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Willems D, Charokopou M, Evers SMAA, Hiligsmann M. Early health economic modelling for a treatment candidate in hidradenitis suppurativa. J Med Econ 2020;23:1516-24. [PMID: 33084453 DOI: 10.1080/13696998.2020.1840181] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
10 Goldburg SR, Strober BE, Payette MJ. Hidradenitis suppurativa: Current and emerging treatments. J Am Acad Dermatol 2020;82:1061-82. [PMID: 31604100 DOI: 10.1016/j.jaad.2019.08.089] [Cited by in Crossref: 12] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
11 Savage KT, Singh V, Patel ZS, Yannuzzi CA, McKenzie-Brown AM, Lowes MA, Orenstein LAV. Pain management in hidradenitis suppurativa and a proposed treatment algorithm. J Am Acad Dermatol 2021;85:187-99. [PMID: 32950543 DOI: 10.1016/j.jaad.2020.09.039] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
12 Esme P, Akoglu G, Caliskan E. Rapid Response to Certolizumab Pegol in Hidradenitis Suppurativa: A Case Report. Skin Appendage Disord 2021;7:58-61. [PMID: 33614722 DOI: 10.1159/000511284] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 4.0] [Reference Citation Analysis]
13 Anduquia-Garay F, Rodríguez-Gutiérrez MM, Poveda-Castillo IT, Valdes-Moreno PL, Agudelo-Rios DA, Benavides-Moreno JS, Lozada-Martínez ID, Bolaño-Romero MP, Borraez-Segura B, Rahman S. Hidradenitis suppurativa: Basic considerations for its approach: A narrative review. Ann Med Surg (Lond) 2021;68:102679. [PMID: 34401142 DOI: 10.1016/j.amsu.2021.102679] [Reference Citation Analysis]
14 Karvar M, Panayi AC, Alavi A, Baziar Z, Orgill DP. Trends in the management of hidradenitis suppurativa in the Middle East region: a systematic review. Int J Dermatol 2020. [PMID: 33615455 DOI: 10.1111/ijd.15293] [Reference Citation Analysis]
15 Langan EA, Recke A, Bokor-Billmann T, Billmann F, Kahle BK, Zillikens D. The Role of the Cutaneous Microbiome in Hidradenitis Suppurativa-Light at the End of the Microbiological Tunnel. Int J Mol Sci 2020;21:E1205. [PMID: 32054085 DOI: 10.3390/ijms21041205] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 10.0] [Reference Citation Analysis]
16 Damiani G, Leone S, Fajgenbaum K, Bragazzi NL, Pacifico A, Conic RR, Pigatto PD, Maiorana C, Poli P, Berti E, Pace MC, Malagoli P, Bettoli V, Fiore M. Nonalcoholic fatty liver disease prevalence in an Italian cohort of patients with hidradenitis suppurativa: A multi-center retrospective analysis. World J Hepatol 2019;11:391-401. [PMID: 31114643 DOI: 10.4254/wjh.v11.i4.391] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
17 Kearney N, Byrne N, Kirby B, Hughes R. Complementary and alternative medicine use in hidradenitis suppurativa. Br J Dermatol 2020;182:484-5. [DOI: 10.1111/bjd.18426] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 van Straalen KR, Tzellos T, Guillem P, Benhadou F, Cuenca-Barrales C, Daxhelet M, Daoud M, Efthymiou O, Giamarellos-Bourboulis EJ, Jemec GBE, Katoulis AC, Koenig A, Lazaridou E, Marzano AV, Matusiak Ł, Molina-Leyva A, Moltrasio C, Pinter A, Potenza C, Romaní J, Saunte DM, Skroza N, Stergianou D, Szepietowski J, Trigoni A, Vilarrasa E, van der Zee HH. The efficacy and tolerability of tetracyclines and clindamycin plus rifampicin for the treatment of hidradenitis suppurativa: Results of a prospective European cohort study. J Am Acad Dermatol 2021;85:369-78. [PMID: 33484766 DOI: 10.1016/j.jaad.2020.12.089] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
19 Taylor EM, Hamaguchi R, Kramer KM, Kimball AB, Orgill DP. Plastic Surgical Management of Hidradenitis Suppurativa. Plast Reconstr Surg 2021;147:479-91. [PMID: 33620946 DOI: 10.1097/PRS.0000000000007677] [Reference Citation Analysis]
20 Gupta AK, Shear NH, Piguet V, Bamimore MA. Efficacy of non-surgical monotherapies for hidradenitis suppurativa: a systematic review and network meta-analyses of randomized trials. J Dermatolog Treat 2021;:1-32. [PMID: 33961535 DOI: 10.1080/09546634.2021.1927949] [Reference Citation Analysis]
21 Hasan SB, Smith SP, Brain A, Mohd Mustapa MF, Cheung ST, Ingram JR, de Berker DAR. British Association of Dermatologists National Clinical Audit on the Management of Hidradenitis Suppurativa in the UK. Clin Exp Dermatol 2021;46:1023-7. [PMID: 33577133 DOI: 10.1111/ced.14598] [Reference Citation Analysis]
22 Ghias MH, Hyde MJ, Tomalin LE, Morgan BP, Alavi A, Lowes MA, Piguet V. Role of the Complement Pathway in Inflammatory Skin Diseases: A Focus on Hidradenitis Suppurativa. J Invest Dermatol 2020;140:531-536.e1. [PMID: 31870626 DOI: 10.1016/j.jid.2019.09.009] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 7.5] [Reference Citation Analysis]
23 Molinelli E, Brisigotti V, Simonetti O, Campanati A, Sapigni C, D'Agostino GM, Giacchetti A, Cota C, Offidani A. Efficacy and safety of topical resorcinol 15% as long-term treatment of mild-to-moderate hidradenitis suppurativa: a valid alternative to clindamycin in the panorama of antibiotic resistance. Br J Dermatol 2020;183:1117-9. [PMID: 32579711 DOI: 10.1111/bjd.19337] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
24 Gáspár K, Hunor Gergely L, Jenei B, Wikonkál N, Kinyó Á, Szegedi A, Remenyik É, Kiss N, Jin X, Sárdy M, Beretzky Z, Péntek M, Gulácsi L, Bánvölgyi A, Brodszky V, Rencz F. Resource utilization, work productivity and costs in patients with hidradenitis suppurativa: a cost-of-illness study. Expert Review of Pharmacoeconomics & Outcomes Research. [DOI: 10.1080/14737167.2021.1895753] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]